Seirei Hamamatsu General Hospital

Running trials

• Recruiting

  Pancreatic Cancer Screening Using the Enzeavour Assay in Japan

  NCT07605819· Cosomil, Inc.· Source

• Recruiting

  Isolated Surgical Aortic Valve Replacement in Low Risk AS Patients

  NCT06924151· Osaka University· Source

• Active, not recruiting

  A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

  NCT06311721· Phase 3· Amgen· Source

• Active, not recruiting

  A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

  NCT06456580· Phase 3· Vor Biopharma· Source

• Active, not recruiting

  A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer

  NCT06532331· Phase 1· Ono Pharmaceutical Co., Ltd.· Source

• Active, not recruiting

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

  NCT05476926· Hoffmann-La Roche· Source

• Recruiting

  Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

  NCT06590896· Phase 2· Ono Pharmaceutical Co., Ltd.· Source

• Recruiting

  Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  NCT05327114· Phase 2/3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer

  NCT06532344· Phase 1· Ono Pharmaceutical Co., Ltd.· Source

• Active, not recruiting

  Japanese Idiopathic Interstitial Pneumonias Registry

  NCT03041623· North East Japan Study Group· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Aortic stenosis1 recruiting
• Epilepsy1 recruiting
• Pancreatic cancer1 recruiting

Closed trials

• Completed

  Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC

  NCT05495425· Phase 3· Nobelpharma· Source

• Completed

  Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan

  NCT05399329· Pfizer· Source

• Terminated

  A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis

  NCT04963270· Phase 3· Hoffmann-La Roche· Source

• Completed

  A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease

  NCT05047263· Phase 3· Bayer· Source

• Completed

  An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Modified FOLFIRINOX (mFFX) or Gemcitabine Plus Nab-paclitaxel (GnP) Therapy as First-line Treatment in Patients With Metastatic Pancreatic Cancer

  NCT06538207· Phase 1· Ono Pharmaceutical Co., Ltd.· Source

• Completed

  Confirm Rx Insertable Cardiac Monitor SMART Registry

  NCT03505801· Abbott Medical Devices· Source

• Completed

  Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

  NCT03025308· Phase 3· Alfasigma S.p.A.· Source

• Completed

  Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease

  NCT02906488· AbbVie· Source

Conditions

Diseases this institution publishes on or runs trials for.

• IgA nephropathy5 works · 0 trials